KRTAP9-7

Across TCGA pan-cancer cohorts, KRTAP9-7 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated KRTAP9-7 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher KRTAP9-7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRTAP9-7 expression acts as an unfavorable survival marker, although some lineages such as UCS show a favorable association.

STAD, UCS, and HNSC are the cancer types where KRTAP9-7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	IV	0.142	0.613	.001	78	view →
UCS	DFS	Tertile	II,III,IV	0.773	0.180	.003	66	view →
HNSC	DFS	Tertile	II,III,IV	0.420	0.689	.020	21	view →
KIRC	DFS	Tertile	IV	0.127	0.630	.039	18	view →
PCPG	DFS	Tertile	All	0.086	0.768	<.001	18	view →
PRAD	OS	Tertile	All	0.959	0.997	.005	12	view →
THCA	DFS	Tertile	All	0.091	0.841	<.001	9	view →
KIRP	DFS	Tertile	All	0.312	0.634	.024	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

KRTAP9-7–STAD (DFS)

Open the STAD breakdown →